Details of the Drug

General Information of Drug (ID: DMFQU7V)

• Drug Name: GC-1102
• Synonyms: Hepabig; HuS10; HBIG, Korea Green Cross; Hepabig-Gene; Recombinant hepatitis B virus immune globulin, Korea Green Cross; Recombinant anti-HBV monoclonal antibody, Green Cross

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Phase 2	[1]

• Cross-matching ID: TTD ID: D0W1QA

References

• [1] ClinicalTrials.gov (NCT02304315) A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients. U.S. National Institutes of Health.